title: [Non-invasive ventilation of elderly patients in the intensive care unit].
abstract: BACKGROUND
  An increasing number of elderly patients, with acute respiratory failure (ARF) due to e.g. COPD exacerbation or cardiac failure, are being referred to intensive care units for mechanical ventilation.
  
  
  BACKGROUND
  NIV can be an effective ventilatory technique in ARF due to a variety of aetiologies. NIV has been shown to decrease endotracheal intubation rates, complication rates and median hospital length of stay. When managing acute-on-chronic respiratory failure, NIV is a first-line ventilatory technique, in the absence of criteria for immediate endotracheal intubation. The efficacy of NIV depends on the expertise of the medical and nursing staff (including physiotherapists) and should always be performed in an appropriate setting. There are very few data about NIV in the elderly but studies, which included patients over 75 years, did not identify different outcomes for this age group.
  
  
  CONCLUSIONS
  Future clinical studies on NIV should allow us to better understand which patients will benefit the most from the technique. Certain specific settings in elderly populations, such as in palliative care or when an "non intubation order" has been given by the patient, his family or the medical/nursing staff, are under evaluation.
  
  
  CONCLUSIONS
  NIV is effective and well tolerated and it has become a key ventilatory technique in the management of ARF, particularly for elderly patients.
authors.affiliation: Service de Pneumologie, Hôpital de Bois-Guillaume, CHU de Rouen, 76031 Rouen Cedex. antoine.cuvelier@chu-rouen.fr
authors.forename: A
authors.initials: A
authors.lastname: Cuvelier
authors.forename: D
authors.initials: D
authors.lastname: Benhamou
authors.forename: J-F
authors.initials: JF
authors.lastname: Muir
mesh_terms: D000208:Acute Disease; D000368:Aged; D005602:France; D006801:Humans; D000860:Hypoxia / Q000628:therapy; D007362:Intensive Care Units; D010166:Palliative Care / Q000379:methods; D029424:Pulmonary Disease, Chronic Obstructive / Q000628:therapy*; D012121:Respiration, Artificial / Q000009:adverse effects / Q000379:methods*; D012131:Respiratory Insufficiency / Q000628:therapy*